Status:
COMPLETED
Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Community-acquired Pneumonia
Eligibility:
All Genders
20-79 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia
Eligibility Criteria
Inclusion
- Patients with community-acquired pneumonia
- Patients with acute respiratory failure
Exclusion
- Patients with nosocomial pneumonia
- Patients on mechanical ventilation
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT00417326
Start Date
December 1 2006
Last Update
June 13 2012
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Chugoku Region
Chugoku, Japan
2
Chubu Region
Chūbu, Japan
3
Hokkaido Region
Hokkaido, Japan
4
Hokuriku Region
Hokuriku, Japan